| Literature DB >> 22853324 |
Trang Vu1, Lesley Day, Caroline F Finch.
Abstract
BACKGROUND: Studies comparing internally linked (person-identifying) and unlinked (episodes of care) hospital discharge data (HDD) on hip fractures have mainly focused on incidence overestimation by unlinked HDD, but little is known about the impact of overestimation on patient profiles such as comorbidity estimates. In view of the continuing use of unlinked HDD in hip fracture research and the desire to apply research results to hip fracture prevention, we concurrently assessed the accuracy of both incidence and comorbidity estimates derived from unlinked HDD compared to those estimated from internally linked HDD.Entities:
Mesh:
Year: 2012 PMID: 22853324 PMCID: PMC3464601 DOI: 10.1186/1471-2288-12-113
Source DB: PubMed Journal: BMC Med Res Methodol ISSN: 1471-2288 Impact factor: 4.615
Figure 1A flow chart of data extraction process. ICD–10–AM – International Classification of Diseases, Tenth Revision, Australian Modification. VAED: Victorian Admitted Episode Dataset.
Selection criteria for linked and unlinked Victorian Admitted Episodes Dataset
| | | | | | | |
| Principal diagnosis hip fracture* | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Admission source coded as “private residence/accommodation” | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| | | | | | | |
| Readmission within 30 days of discharge | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Readmission within 120 days of discharge | ✓ | | | ✓ | ✓ | ✓ |
| Discharge status denoting in-hospital death | | ✓ | | ✓ | ✓ | |
| Hip revision procedures only | ✓ | | | | ✓ | ✓ |
| Non-acute care type | ✓ | | | | ✓ | ✓ |
| Non-emergency admission | ✓ | ✓ | ✓ |
S1 – Scenario 1. S2 – Scenario 2. S3 – Scenario 3. S4 – Scenario 4.
* S72.0–S72.2 in International Classification of Diseases, Tenth Revision, Australian Modification.
Sensitivity, specificity, positive and negative predictive values of unlinked data in identifying incident fall-related hip fractures
| | ||||||
|---|---|---|---|---|---|---|
| No hip fractures | N=10,110 | N=11,110 | N=11,746 | N=11,056 | N=10,173 | N=10,765 |
| Overestimation | NA | 9.9% | 16.2% | 9.4% | 0.6% | 6.5% |
| Sensitivity | | 94.4% (94.0–94.9) | 99.8% (99.7–99.9) | 94.4% (93.9–94.8) | 94.4% (93.9–94.8) | 99.7% (99.6–99.8) |
| Specificity | | 97.5% (97.4–97.6) | 97.4% (97.2–97.5) | 97.6% (97.5–97.7) | 99.0% (98.9–99.1) | 98.9% (98.8–99.0) |
| PPV | | 85.9% (85.3–86.6) | 85.9% (85.2–86.5) | 86.3% (85.7–87.0) | 93.8% (93.3–94.3) | 93.7% (93.2–94.1) |
| NPV | 99.1% (99.0–99.2) | 100.0% (99.9–100.0) | 99.0% (99.0–99.2) | 99.1% (99.0–99.2) | 100.0% (99.9–100.0) |
Note values are percentages (95% confidence intervals) unless stated otherwise. True negatives were community-dwelling Victorian population aged 65+ years hospitalised for fall-related injury other than a hip fracture between 2005/06 and 2007/08.
NA – Not applicable. PPV – Positive predictive value. NPV – Negative predictive value. CI – confidence intervals.
Comorbidities in community-dwelling older people hospitalised for fall-related hip fracture by data source
| Any comorbidity | 37.3 (36.3–38.2) | 30.7 (29.8– 31.5) | 32.0 (31.2–32.9) | 31.2 (30.3– 32.1) | 32.6 (31.7– 33.5) |
| Diabetes | 5.4 (4.9–5.8) | 4.4 (4.0–4.8) | 4.5 (4.1–4.9) | 4.5 (4.1–4.9) | 4.5 (4.1–4.9) |
| Diabetes complications | 5.3 (4.8–5.7) | 4.2 (3.8 –4.6) | 4.4 (4.1–4.8) | 4.3 (3.9–4.7) | 4.5 (4.1–4.9) |
| Renal disease | 7.6 (7.1–8.1) | 5.8 (5.4 –6.3) | 6.5 (6.1–7.0) | 6.0 (5.5–6.5) | 6.7 (6.3–7.2) |
| Dementia | 7.1 (6.6–7.6) | 5.6 (5.2 –6.1) | 5.8 (5.3–6.2) | 5.8 (5.4–6.3) | 6.0 (5.6–6.5) |
| Congestive heart failure | 5.7 (5.3–6.2) | 4.0 (3.6 –4.4) | 4.8 (4.4–5.2) | 4.1 (3.7–4.5) | 4.9 (4.5–5.3) |
| Pulmonary disease | 4.3 (3.9–4.7) | 3.2 (2.9 –3.6) | 3.6 (3.2–3.9) | 3.3 (3.0–3.7) | 3.6 (3.3–4.0) |
| Osteoporosis | 3.9 (3.5–4.3) | 4.3 (3.9 –4.7) | 4.3 (3.9–4.6) | 4.4 (4.0–4.8) | 4.3 (3.9–4.7) |
| Parkinson’s disease | 3.0 (2.7–3.3) | 2.7 (2.5-3.1) | 2.7 (2.4–3.0) | 2.7 (2.4–3.0) | 2.7 (2.4–3.0) |
| Delirium | 2.6 (2.3–2.9) | 1.8 (1.6–2.1) | 1.9 (1.7–2.2) | 1.9 (1.7–2.2) | 2.0 (1.8–2.3) |
| Cerebral vascular accident | 2.2 (1.9–2.5) | 1.6 (1.4–1.9) | 1.6 (1.4–1.9) | 1.7 (1.4–1.9) | 1.7 (1.4–1.9) |
| AMI | 2.0 (1.7–2.2) | 1.3 (1.1–1.5) | 1.5 (1.3–1.7) | 1.3 (1.1–1.6) | 1.5 (1.3 –1.8) |
| Cancer | 1.8 (1.6–2.1) | 1.5 (1.3–1.8) | 1.6 (1.4– 1.9) | 1.5 (1.3–1.7) | 1.6 (1.4–1.9) |
| Vision impairment | 1.7 (1.5–2.0) | 1.3 (1.1–1.5) | 1.3 (1.1– 1.5) | 1.3 (1.1–1.6) | 1.3 (1.1– 1.5) |
| Deafness | 1.4 (1.2–1.7) | 1.0 (0.8–1.2) | 1.0 (0.8– 1.2) | 1.0 (0.8–1.2) | 1.0 (0.9– 1.3) |
| Paraplegia | 1.3 (1.1–1.5) | 0.9 (0.8–1.1) | 0.9 (0.8– 1.1) | 1.0 (0.8–1.2) | 1.0 (0.8–1.1) |
Note values are percentages (95% confidence intervals) unless stated otherwise. Results for Scenario 2 are identical or almost identical to those in the base case and hence not shown here. Prevalence <1% not presented (metastatic cancer, peripheral vascular disease, peptic ulcer, liver disease, severe liver disease, ataxia, human immunodeficiency virus and connective tissue disorder).
AMI – Acute myocardial infarction.